12 March 2019 in The Journal of Clinical Endocrinology & Metabolism
AHAura D Herrera-Martínez
+11
Context Pituitary neuroendocrine tumors (PitNETs) comprise a commonly underestimated pathology in terms of incidence and associated morbimortality. Currently, an appreciable subset of patients is resistant or poorly responsive to the main current medical treatments [i.e. somatostatin-analogues (SSAs)/dopamine-agonists]. Thus, development/optimization of novel/available medical therapies is necessary. Biguanides (metformin/buformin/phenformin) are antidiabetic drugs that exert antitumoral actions in several tumor types, but their pharmacological effects on PitNETs are poorly known. Objective We aimed to explore the direct effects of biguanides on key functions (cell-viability/hormone-release/apoptosis/signaling-pathways) in primary cell-cultures from human PitNETs and cell-lines. Additionally, we evaluated the combination of metformin with SSAs on cell-viability and hormone secretion. Design A total of 13 corticotropinomas, 13 somatotropinomas, 13 non-functioning PitNETs, 3 prolactinomas and two tumoral pituitary cell-lines (AtT-20 and GH3) were used to evaluate the direct effects of biguanides on cell-viability, hormone-release, apoptosis and signaling-pathways. Results Biguanides reduced cell-viability in all PitNETs and cell-lines (being phenformin the most effective biguanide), and increased apoptosis in somatotropinomas. Moreover, buformin and phenformin, but not metformin, reduced hormone secretion in a cell-type specific manner. Combination metformin-SSAs therapy did not enhance SSAs monotherapy effectiveness. Effects of biguanides on PitNETs could involve the modulation of AMPK-dependent ([Ca2+]i, PI3K/Akt) and independent (MAPK) mechanisms. Conclusion Altogether, our data unveil clear antitumoral effects of biguanides on PitNET cells, opening new avenues to explore their potential as drugs to treat these pathologies.
18 April 2018 in Scientific Reports
MAMaría R. Alhambra-Expósito
María R. Alhambra-Expósito
+7
Acromegaly is a rare but severe disease, originated in 95% of cases by a growth hormone-secreting adenoma (somatotropinoma) in the pituitary. Magnetic resonance imaging (MRI) is a non-invasive technique used for the diagnosis and prognosis of pituitary tumours. The aim of this study was to determine whether the use of T2-weighted signal intensity at MRI could help to improve the characterisation of somatotropinomas, by analysing its relationship with clinical/molecular features. An observational study was implemented in a cohort of 22 patients (mean age = 42.1 ± 17.2 years; 59% women; 95% size>10 mm). Suprasellar-extended somatotropinomas presented larger diameters vs. non-extended tumours. T2-imaging revealed that 59% of tumours were hyperintense and 41% isointense adenomas, wherein hyperintense were more invasive (according to Knosp-score) than isointense adenomas. A higher proportion of hyperintense somatotropinomas presented extrasellar-growth, suprasellar-growth and invasion of the cavernous sinus compared to isointense adenomas. Interestingly, somatostatin receptor-3 and dopamine receptor-5 (DRD5) expression levels were associated with extrasellar and/or suprasellar extension. Additionally, DRD5 was also higher in hyperintense adenomas and its expression was directly correlated with Knosp-score and with tumour diameter. Hence, T2-weighted MRI on somatotropinomas represents a potential tool to refine their diagnosis and prognosis, and could support the election of preoperative treatment, when required.
3 October 2016 in International Journal of Endocrinology
MAMaría Rosa Alhambra-Expósito
María Rosa Alhambra-Expósito
MGMaría Angeles Gálvez-Moreno
María Angeles Gálvez-Moreno
+1
Objective. The aim of this study was to assess the utility of arterial calcium stimulation with hepatic venous sampling (ASVS) in the localization diagnosis of endogenous hyperinsulinism.Patients and Methods. A retrospective descriptive study was performed including patients with endogenous hyperinsulinism who underwent ASVS. The histopathological diagnosis in patients who underwent a surgical procedure was used as the reference for the statistical study of the accuracy of this technique.Results. 30 patients were included with endogenous hyperinsulinism and nonconclusive imaging diagnosis was included. ASVS was performed in all cases. Surgery was performed in 20 cases. Insulinoma was removed in 19 patients; the location of all cases was detected in the ASVS. All cases of endogenous hyperinsulinism had a positive result for the ASVS, with this association being statistically significant (;). A good and statistically significant agreement was obtained between histopathologic diagnosis and ASVS results (,).Conclusions. ASVS is a useful procedure in the localization diagnosis of endogenous hyperinsulinism undetected by other imaging tests. This technique allows the localization of intrapancreatic insulinomas and represents useful tool for the diagnosis and surgical management of these tumors.
31 January 2013 in Endocrinología y Nutrición
MMMaría Ángeles Gálvez Moreno
María Ángeles Gálvez Moreno
CJConcepción Muñoz Jiménez
1 March 2010 in Endocrinología y Nutrición
MMMaría del Carmen Muñoz-Villanueva
María del Carmen Muñoz-Villanueva
RORafael Palomares Ortega
MJMaría del Sierra Corpas Jiménez
María del Sierra Corpas Jiménez
+1